http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2013138180-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0051 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 |
filingDate | 2012-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2015-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2013138180-A |
titleOfInvention | METHODS FOR TREATMENT OF MACULAR Edema WITH THE USE OF ANTI-DRAINAGE MEDICINES |
abstract | 1. A method of treating macular edema in a patient, comprising determining whether the patient has been diagnosed with macular edema or if the patient experiences symptoms of macular edema within a predetermined period of time, or determining whether the patient has a significant deterioration in visual acuity, or determining both of them; and if the patient experiences symptoms of macular edema for a predetermined period of time or, optionally, has a significant deterioration in visual acuity, the administration of a therapeutically effective amount of decongestant drug (POL) to the patient. 2. A method of treating macular edema in a patient, comprising determining whether the patient experiences symptoms of macular edema for a predetermined period of time; optionally, determining whether the patient has a significant deterioration in visual acuity; and if the patient does not experience symptoms of macular edema for a predetermined period of time or, optionally, does not have a significant deterioration in visual acuity, treating the patient with other types of therapy other than decongestant drug (POL). 3. A method for treating macular edema in a patient, comprising determining whether the patient has been diagnosed with macular edema within a predetermined period of time, or determining whether the patient has a significant deterioration in visual acuity, or determining both of them; and if the patient is diagnosed with macular edema within a predetermined period of time or, optionally, the patient has a significant deterioration in visual acuity, the introduction of a therapeutically effective |
priorityDate | 2011-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 75.